Regulation and therapy: the role of ferroptosis in DLBCL

Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of B-cell non-Hodgkin’s lymphoma (NHL), up to 30%–40% of patients will relapse and 10%–15% of patients have primary refractory disease, so exploring new treatment options is necessary. Ferroptosis is a non-apoptotic cell death mode dis...

詳細記述

書誌詳細

出版年:	Frontiers in Pharmacology
主要な著者:	Yifan Wang, Zhengmei He, Xinyu Dong, Yiming Yao, Qiuni Chen, Yuye Shi, Yuan Deng, Quane Zhang, Liang Yu, Chunling Wang
フォーマット:	論文
言語:	英語
出版事項:	Frontiers Media S.A. 2025-01-01
主題:	ferroptosis STAT3 Nfr2 ZEB1 IKE α-KG
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1458412/full